|
Name |
2,4-Diaminomesitylene
|
Molecular Formula | C9H14N2 | |
IUPAC Name* |
2,4,6-trimethylbenzene-1,3-diamine
|
|
SMILES |
CC1=CC(=C(C(=C1N)C)N)C
|
|
InChI |
InChI=1S/C9H14N2/c1-5-4-6(2)9(11)7(3)8(5)10/h4H,10-11H2,1-3H3
|
|
InChIKey |
ZVDSMYGTJDFNHN-UHFFFAOYSA-N
|
|
Synonyms |
3102-70-3; 2,4-Diaminomesitylene; 2,4,6-Trimethylbenzene-1,3-diamine; 2,4,6-Trimethyl-1,3-phenylenediamine; 2,4,6-Trimethyl-m-phenylenediamine; 1,3-Benzenediamine, 2,4,6-trimethyl-; 2,4-Mesitylenediamine; 2,4,6-Trimethyl-1,3-benzenediamine; 9K3JRF5932; NSC-10392; 1,3-diamino-2,4,6-trimethylbenzene; 2,4-Diamino-1,3,5-trimethylbenzene; CCRIS 6520; EINECS 221-456-9; BRN 2717221; NSC10392; 3MPDA; Cambridge id 5180400; 1, 2,4,6-trimethyl-; 3-13-00-00343 (Beilstein Handbook Reference); SCHEMBL262306; UNII-9K3JRF5932; CHEMBL1998053; 2,6-Trimethyl-m-phenylenediamine; DTXSID40184994; ZINC391994; m-Phenylenediamine,4,6-trimethyl-; ACT07451; ALBB-014271; MFCD00010149; NSC 10392; m-Phenylenediamine,2,4,6-trimethyl-; AKOS005174343; 2,4,6-Trimethyl-1,3-benzenediamine #; AS-12571; NCI60_000097; 2,4,6-Trimethyl-m-phenylenediamine, 96%; DB-005852; CS-0145866; FT-0609973; T1275; 1,3,5-TRIMETHYL-2,6-BENZENEDIAMINE; D83806; EN300-7366611; A820695; Q27894392; 858865-47-1
|
|
CAS | 3102-70-3 | |
PubChem CID | 76547 | |
ChEMBL ID | CHEMBL1998053 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.22 | ALogp: | 1.7 |
HBD: | 2 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 52.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.558 |
Caco-2 Permeability: | -4.637 | MDCK Permeability: | 0.00013065 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.685 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.075 |
30% Bioavailability (F30%): | 0.693 |
Blood-Brain-Barrier Penetration (BBB): | 0.577 | Plasma Protein Binding (PPB): | 52.29% |
Volume Distribution (VD): | 1.369 | Fu: | 62.21% |
CYP1A2-inhibitor: | 0.272 | CYP1A2-substrate: | 0.754 |
CYP2C19-inhibitor: | 0.055 | CYP2C19-substrate: | 0.909 |
CYP2C9-inhibitor: | 0.013 | CYP2C9-substrate: | 0.124 |
CYP2D6-inhibitor: | 0.161 | CYP2D6-substrate: | 0.83 |
CYP3A4-inhibitor: | 0.017 | CYP3A4-substrate: | 0.307 |
Clearance (CL): | 9.062 | Half-life (T1/2): | 0.322 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.583 |
Drug-inuced Liver Injury (DILI): | 0.37 | AMES Toxicity: | 0.166 |
Rat Oral Acute Toxicity: | 0.058 | Maximum Recommended Daily Dose: | 0.929 |
Skin Sensitization: | 0.869 | Carcinogencity: | 0.441 |
Eye Corrosion: | 0.263 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.49 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000181 | 0.385 | D0FA2O | 0.250 | ||||
ENC002336 | 0.366 | D0X0RI | 0.235 | ||||
ENC005230 | 0.366 | D01PJR | 0.226 | ||||
ENC000342 | 0.350 | D0Y4DY | 0.222 | ||||
ENC000180 | 0.333 | D09EBS | 0.215 | ||||
ENC000364 | 0.333 | D0L5FY | 0.211 | ||||
ENC001498 | 0.298 | D0U3DU | 0.207 | ||||
ENC001026 | 0.295 | D05YBZ | 0.206 | ||||
ENC000084 | 0.286 | D09TBD | 0.203 | ||||
ENC001359 | 0.283 | D0X5NX | 0.200 |